[Treatment of urogenital trichomoniasis of both sexes with tinidazol (Fasygin)].
D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D051379:Mice; D009574:Nitro Compounds / Q000627:therapeutic use; D012737:Sex Factors; D013450:Sulfones / Q000627:therapeutic use; D014245:Trichomonas Infections / Q000188:drug therapy*; D014247:Trichomonas Vaginitis / Q000188:drug therapy; D014246:Trichomonas vaginalis / Q000187:drug effects
D000981:Antiprotozoal Agents; D007093:Imidazoles; D009574:Nitro Compounds; D013450:Sulfones; D008795:Metronidazole
Uber die Behandlung der Trichomoniasis urogenitalis beider Geschlechter mit Tinidazol (Fasygin)